[1] Massella V, Pietropaolo A, Gauhar V, et al. Has fluoroless endourology (URS and PCNL) come of age? evidence from a comprehensive literature review[J]. Actas Urol Esp (Engl Ed), 2023, 16:2173-5786. [2] Atassi N, Knoll T. Future of kidney stone management: surgical intervention miniaturization of PCNL: Where is the limit?[J] Curr Opin Urol, 2020, 30:107-112. [3] Sigurdarson JJ, Svane S, Karring H. Development of a M9-based urea medium (M9U) for sensitive and real-time monitoring of ureolytic activity of bacteria and cell-free urease[J]. Microbiologyopen, 2020, 9:e976. doi: 10.1002/mbo3.976. [4] Cron MA, Guillochon É, Kusner L, et al. Role of miRNAs in normal andmyasthenia gravis thymus[J]. Front Immunol, 2020, 11:1074.doi: 10.3389/fimmu.2020.01074. [5] Di Martino MT, Arbitrio M, Caracciolo D, et al. miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: a systematic review[J]. Mol Ther Nucleic Acids, 2022, 27:1191-1224. [6] 叶章群. 泌尿外科疾病诊疗指南[M]. 北京:科学出版社, 2013:78-79. [7] 李晓慧, 岳胜, 杜小静, 等. ICU重症感染患者血清C-反应蛋白、内毒素、肝素结合蛋白水平及其预测价值[J]. 中华医院感染学杂志, 2020, 30:2647-2651. [8] 查娜,郝丹丹,李天柱.MicroRNAs通过Hippo通路抑制肝细胞癌发生的研究进展[J]. 基础医学与临床,2023,43:1871-1875. [9] Liu Z, Yang D, Gao J, et al. Discovery and validation of miR-452 as an effective biomarker for acute kidney injury in sepsis[J]. Theranostics, 2020, 10:11963-11975. [10] Markovic J, Sharma AD, Balakrishnan A. MicroRNA-221: a fine tuner and potential biomarker of chronic liver injury[J]. Cells, 2020, 9:1767.doi: 10.3390/cells9081767. [11] Gaytán-Pacheco N, Ibáñez-Salazar A, Herrera-Van Oostdam AS, et al. miR-146a, miR-221, and miR-155 are involved in inflammatory immune response in severe COVID-19 patients[J]. Diagnostics (Basel), 2022, 13:133. doi: 10.3390/diagnostics13010133. [12] Shi B, Zhang J, Chen Q. Liver and kidney surgical anatomy to verify the effect of miR-221 on organ damage in septic rats[J]. J Healthc Eng, 2022, 2022:2814431.doi: 10.1155/2022/2814431. |